Endoscopic versus surgical therapy for Barrett’s esophagus neoplasia

References

• Pohl H, Sonnenberg A, Strobel S, et al. Endoscopic versus surgical therapy for early cancer in Barrett’s esophagus: a decision analysis. Gastrointest Endosc 2009;70(4):623-31
   PubMed Web of Science ®Google Scholar
• Wu J, Pan Y, Wang T, et al. Endotherapy versus surgery for early neoplasia in Barrett’s. Gastrointest Endosc 2014;79(2):233-41
   PubMed Web of Science ®Google Scholar
• Pacifico RJ, Wang KK, Wongkeesong LM, et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. Clin Gastroenterol Hepatol 2003;1(4):252-7
   PubMed Web of Science ®Google Scholar
• Ell C, May E, Pech O, et al. Curative endoscopic resection of early esophageal adenocarcinoma (Barrett’s cancer). Gastrointest Endosc 2007;65:3-10
   PubMed Web of Science ®Google Scholar
• Das A, Singh V, Fleischer DE, et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008;103(6):1340-5
   PubMed Web of Science ®Google Scholar
• Schembre DB, Huang JL, Lin OS, et al. Treatment of Barrett’s esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 2008;67(4):595-601
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Inadomi JM, Overholt BF, et al. What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis. Gut 2004;53(12):1736-44
   PubMed Web of Science ®Google Scholar
• Hur C, Nishioka NS, Gazelle GS. Cost-effectiveness of photodynamic therapy for treatment of Barrett’s esophagus with high grade dysplasia. Dig Dis Sci 2003;48(7):1273-83
   PubMed Web of Science ®Google Scholar
• Vij R, Triadafilopoulos G, Owens DK, et al. Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest Endosc 2004;60(5):739-56
   PubMed Web of Science ®Google Scholar
• Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 2007;132(4):1226-33
   PubMed Web of Science ®Google Scholar
• Zehetner J, DeMeester SR, Hagen JA, et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg 2011;141(1):39-47
   PubMed Web of Science ®Google Scholar
• Ngamruengphong S, Wolfsen HC, Wallace MB. Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery. Clin Gastroenterol Hepatol 2013;11(11):1424-9
   PubMed Web of Science ®Google Scholar
• Pech O. Nonneoplastic and neoplastic Barrett’s esophagus: the European perspective. Digest Dis 2013;31:17-20
   PubMed Web of Science ®Google Scholar
• Yachimski P, Nishioka NS, Richards E, Hur C. Treatment of Barrett’s esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol 2008;6(11):1206-11
   PubMed Web of Science ®Google Scholar
• Dunbar KB, Spechler SJ. The risk of lymph node metastases in patients with high grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 2012;107(6):850-63
   PubMed Web of Science ®Google Scholar
• Oyama T. Diagnostic strategies of superficial Barrett’s esophageal cancer for endoscopic submucosal dissection. Digest Endosc 2013;25(Suppl 1):7-12
   PubMed Web of Science ®Google Scholar
• Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of barrett’s esophagus. Am J of Gastroenterol 2008;103:788-97
   PubMed Web of Science ®Google Scholar
• Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol 2013;19(9):1424-37
   PubMed Web of Science ®Google Scholar
• Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005;446(5):497-504
   PubMed Web of Science ®Google Scholar
• Bollschweiler E, Baldus SE, Schroder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006;38(2):149-56
   PubMed Web of Science ®Google Scholar
• Manner H, May A, Pech O, et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008;103(10):2589-97
   PubMed Web of Science ®Google Scholar
• Vieth M, Rosch T. Endoscopic mucosal resection and the risk of lymph-node metastases: indications revisited? Endoscopy 2006;38(2):175-9
   PubMed Web of Science ®Google Scholar
• Ciorcirlan M, Lapalus MG, Hervieu V, et al. Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus. Endoscopy 2007;39(1):24-9
   PubMed Web of Science ®Google Scholar
• Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008;57(9):1200-6
   PubMed Web of Science ®Google Scholar
• Van Vilsteren FG, Pou RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomized trial. Gut 2011;60(6):765-73
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Greenwald BD, Peery AF, et al. Safety and Efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 2010;71(4):680-5
   PubMed Web of Science ®Google Scholar